Early Discharge Clinic: A Quality Improvement Initiative to Create a Safe and Efficient Model for Intensive Outpatient Management of Hematologic Malignancies

PURPOSE Intensive treatment regimens for hematologic malignancies often lead to prolonged hospitalizations, strained inpatient resources, and reduced quality of life. Standard outpatient clinic models are frequently unable to support early discharge for these high-acuity patients. To address this local care-delivery gap, Northwell Health established New York State's first Early Discharge Clinic (EDC). We herein describe EDC operationalization and initial outcomes and compare the average hospital length of stay (ALOS) with historical Northwell Health's EDC for Hematologic Malignancies controls. METHODS This quality improvement initiative proposed a structured EDC for patients with hematologic malignancies enrolled in 2023 and 2024. Eligible patients were identified during inpatient admissions and selected for early discharge based on clinical stability, supportive care needs, and logistical readiness for frequent outpatient follow-up. The EDC incorporated nine operational pillars supporting high-acuity outpatient care. Performance measures were selected to assess utilization (visit frequency, blood product utilization), timeliness of supportive care (time to antibiotic administration), safety (nonscheduled readmissions within 48 hours and 7 days after discharge, mortality), and efficiency (ALOS). RESULTS The program accrued 191 enrollments from 112 unique individuals. Patients received a median of five structured evaluations, and most required blood product support. Neutropenic fever occurred in 36 of 191 enrollments; the median time to antimicrobial administration was 46 minutes (range, 6-131 minutes). There were no unplanned readmissions within 48 hours of discharge, and 11 within 7 days. No outpatient mortality occurred. EDC implementation reduced ALOS by 10.2 days, corresponding to a 39.7% reduction ( P = .00025). CONCLUSION The EDC demonstrated a safe and effective model for early outpatient management of selected patients undergoing therapy for hematologic malignancies. These findings support the EDC as a practical framework for improving efficiency and reducing hospitalization while maintaining timely high-acuity care.

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2026-05-19
DOI
https://doi.org/10.1200/op-25-01313
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early Discharge Clinic: A Quality Improvement Initiative to Create a Safe and Efficient Model for Intensive Outpatient Management of Hematologic Malignancies

Stéphanie Boisclair, B. Mockler, Joo Yeon Seo, Monica Wallin et al.
JCO Oncology Practice
Neutropenia and Cancer Infections
article

Early Discharge Clinic: A Quality Improvement Initiative to Create a Safe and Efficient Model for Intensive Outpatient Management of Hematologic Malignancies

Stéphanie Boisclair, B. Mockler, Joo Yeon Seo, Monica Wallin, Teshmanie Rampersaud, Douglas E. Gladstone, Nadine Lugo-Bibbo, Christina A. Mallilo
article en

Abstract

PURPOSE Intensive treatment regimens for hematologic malignancies often lead to prolonged hospitalizations, strained inpatient resources, and reduced quality of life. Standard outpatient clinic models are frequently unable to support early discharge for these high-acuity patients. To address this local care-delivery gap, Northwell Health established New York State's first Early Discharge Clinic (EDC). We herein describe EDC operationalization and initial outcomes and compare the average hospital length of stay (ALOS) with historical Northwell Health's EDC for Hematologic Malignancies controls. METHODS This quality improvement initiative proposed a structured EDC for patients with hematologic malignancies enrolled in 2023 and 2024. Eligible patients were identified during inpatient admissions and selected for early discharge based on clinical stability, supportive care needs, and logistical readiness for frequent outpatient follow-up. The EDC incorporated nine operational pillars supporting high-acuity outpatient care. Performance measures were selected to assess utilization (visit frequency, blood product utilization), timeliness of supportive care (time to antibiotic administration), safety (nonscheduled readmissions within 48 hours and 7 days after discharge, mortality), and efficiency (ALOS). RESULTS The program accrued 191 enrollments from 112 unique individuals. Patients received a median of five structured evaluations, and most required blood product support. Neutropenic fever occurred in 36 of 191 enrollments; the median time to antimicrobial administration was 46 minutes (range, 6-131 minutes). There were no unplanned readmissions within 48 hours of discharge, and 11 within 7 days. No outpatient mortality occurred. EDC implementation reduced ALOS by 10.2 days, corresponding to a 39.7% reduction ( P = .00025). CONCLUSION The EDC demonstrated a safe and effective model for early outpatient management of selected patients undergoing therapy for hematologic malignancies. These findings support the EDC as a practical framework for improving efficiency and reducing hospitalization while maintaining timely high-acuity care.

JCO Oncology Practice
Northwell Health (US), North Shore Diabetes and Endocrine Associates (US)
Openalex Percentile: Top 6%
Neutropenia and Cancer Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.